Response to SMAC mimetics in patient-derived models of triple-negative breast cancer relies on RIPK1 activation.

Journal: bioRxiv : the preprint server for biology •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Brown E, Jensen P, Yang CH, et al. (2026). "Response to SMAC mimetics in patient-derived models of triple-negative breast cancer relies on RIPK1 activation.". bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.10.26.761582